|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
October 09, 2013
Health Tip: Worried About Excessive Sweating?
(HealthDay News) -- Excessive sweating, medically called hyperhidrosis, usually affects any combination of the underarms, palms, soles or groin.
Health Tip: Operate a Slow Cooker Safely
(HealthDay News) -- A slow cooker is a handy tool that can cook all day long so you can enjoy a healthy meal without a lot of preparation.
Chronic Exposure to Airplane Noise Might Harm the Heart: Study
WEDNESDAY, Oct. 9 (HealthDay News) -- People who put up with the constant roar of aircraft overhead may be at higher risk for heart disease, two new studies suggest.
Early Puberty Tied to Higher Odds of Substance Use in Teens: Survey
WEDNESDAY, Oct. 9 (HealthDay News) -- Teens who began puberty at an early age are more likely to experiment with cigarettes, alcohol and marijuana, researchers report.
Efforts to Improve Intensive-Care Outcomes Produce Mixed Results
WEDNESDAY, Oct. 9 (HealthDay News) -- Three different efforts to improve outcomes among patients in intensive-care units have produced mixed results.
Controversial Treatment May Not Help MS Patients
TUESDAY, Oct. 8 (HealthDay News) -- A theory claiming that multiple sclerosis (MS) is caused by the narrowing of veins in the neck appears to be unfounded, Canadian researchers report.
Do Breast Implants Boost Women's Sex Lives?
WEDNESDAY, Oct. 9 (HealthDay News) -- Women who got breast implants said the surgery spiced up their sex lives, a small, preliminary study found.
Health Highlights: Oct. 9, 2013
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
State-Run Health Exchanges Off to Smoother Start: Report
WEDNESDAY, Oct. 9 (HealthDay News) -- Unlike the highly publicized problems that have plagued the federal health exchange website created to help Americans register for insurance coverage, many state-run exchanges are operating well, according to published reports.
Adempas Approved to Treat Pulmonary Hypertension
WEDNESDAY, Oct. 9 (HealthDay News) -- Adempas (riociguat) has been approved by the U.S. Food and Drug Administration to treat two types of pulmonary hypertension, characterized by high blood pressure in the arteries of the lungs.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at email@example.com. Our Health Library Support team will respond to your email request within 2 business days.